AIkido Pharma Stock Forecast, Price & News

AIkido Pharma (NASDAQ:AIKI) Frequently Asked Questions

Is AIkido Pharma a buy right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for AIkido Pharma in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" AIkido Pharma stock.
View analyst ratings for AIkido Pharma or view top-rated stocks.

What stocks does MarketBeat like better than AIkido Pharma?

Wall Street analysts have given AIkido Pharma a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AIkido Pharma wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting AIkido Pharma?

AIkido Pharma saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 678,000 shares, an increase of 43.5% from the September 15th total of 472,600 shares. Based on an average daily trading volume, of 3,130,000 shares, the short-interest ratio is currently 0.2 days. Approximately 2.0% of the company's shares are sold short.
View AIkido Pharma's Short Interest.

When is AIkido Pharma's next earnings date?

AIkido Pharma is scheduled to release its next quarterly earnings announcement on Friday, November 12th 2021.
View our earnings forecast for AIkido Pharma.

How were AIkido Pharma's earnings last quarter?

AIkido Pharma Inc. (NASDAQ:AIKI) posted its earnings results on Wednesday, August, 11th. The business services provider reported ($0.02) EPS for the quarter.
View AIkido Pharma's earnings history.

How has AIkido Pharma's stock price been impacted by COVID-19 (Coronavirus)?

AIkido Pharma's stock was trading at $1.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, AIKI stock has decreased by 58.2% and is now trading at $0.8324.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for AIKI?

1 analysts have issued twelve-month target prices for AIkido Pharma's stock. Their forecasts range from $2.00 to $2.00. On average, they expect AIkido Pharma's share price to reach $2.00 in the next year. This suggests a possible upside of 140.3% from the stock's current price.
View analysts' price targets for AIkido Pharma or view top-rated stocks among Wall Street analysts.

Who are AIkido Pharma's key executives?

AIkido Pharma's management team includes the following people:

• Anthony C. Hayes, CEO, Chief Financial Officer & Director (LinkedIn Profile)

Who are some of AIkido Pharma's key competitors?

Some companies that are related to AIkido Pharma include CM Life Sciences II (CMII), Luna Innovations (LUNA), Auxly Cannabis Group (CBWTF), Eloxx Pharmaceuticals (ELOX), LifeSci Acquisition II (LSAQ), Bioqual (BIOQ), Inhibitor Therapeutics (INTI), HedgePath Pharmaceuticals (HPPI), iSpecimen (ISPC), ProMIS Neurosciences (ARFXF), Vitality Biopharma (VBIO), U.S. Stem Cell (USRM), Protalex (PRTX), DNAPrint Genomics (DNAG) and Affinity Energy and Health (ALGXY).
View all of AIKI's competitors.

What other stocks do shareholders of AIkido Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AIkido Pharma investors own include Biocept (BIOC), AIM ImmunoTech (AIM), Nuwellis (CHFS), Foresight Autonomous (FRSX), iBio (IBIO), Exela Technologies (XELA), Bionano Genomics (BNGO), Check-Cap (CHEK), Digital Ally (DGLY) and Purple Biotech (KTOV).

What is AIkido Pharma's stock symbol?

AIkido Pharma trades on the NASDAQ under the ticker symbol "AIKI."

How do I buy shares of AIkido Pharma?

Shares of AIKI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is AIkido Pharma's stock price today?

One share of AIKI stock can currently be purchased for approximately $0.83.

How much money does AIkido Pharma make?

AIkido Pharma has a market capitalization of $74.65 million and generates $10,000.00 in revenue each year.

How many employees does AIkido Pharma have?

AIkido Pharma employs 5 workers across the globe.

Does AIkido Pharma have any subsidiaries?

The following companies are subsidiares of AIkido Pharma: Hoth Therapeutics.

When was AIkido Pharma founded?

AIkido Pharma was founded in 1967.

What is AIkido Pharma's official website?

The official website for AIkido Pharma is www.spherix.com.

Where are AIkido Pharma's headquarters?

AIkido Pharma is headquartered at ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY, 10020.

How can I contact AIkido Pharma?

AIkido Pharma's mailing address is ONE ROCKEFELLER PLAZA 11TH FLOOR, NEW YORK NY, 10020. The business services provider can be reached via phone at (112) 745-1374 or via email at [email protected].